ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 39351 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 39351; 2) Community: the network communities that were significantly associated with the response to NSC 39351; 3) Molecule: the relationships between components within communities and NSC 39351; 4) MDR: the compounds that were significantly associated with the NSC 39351.

NSC Compound Enrichment Correlation
NSC 661820 Null 0.0376362543535815 0.10050952
NSC 664314 Null 0.0376362543535815 0.16401553
NSC 671009 2H-Thieno[3',4':4,5]cyclopent[1,2-d]oxazole- 2,7(7aH)-dione,4,6-dibromo-3,3a-dihydro- 0.0376362543535815 0.51175701
NSC 671174 Null 0.0376362543535815 0.32260236
NSC 672073 Null 0.0376362543535815 0.060711459
NSC 673452 Null 0.0376362543535815 0.29122014
NSC 678345 1S,5S-8-(E)-Benzylidene-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one, perchlorate 0.0376362543535815 0.22389328
NSC 678636 Benzoic acid, 4-[[(3,6-dioxo-1,4-cyclohexadienyl)methyl]amino]-, benzyl ester 0.0376362543535815 0.15468134
NSC 681635 Camptothecin Derivative 0.0376362543535815 -0.053012655
NSC 683662 2-Azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaene- 3,20,22-trione, 9-[[(amino)carbonyl]oxy]-8,14-dimethoxy- 4,10,12,16-tetramethyl-13-[2-(dimethylamino)-1-oxoethoxy]-19-[(2-propenyl)amino]-, stereo 0.0376362543535815 0.31913823
Total:110  Current:86    [First] [Prev] [Next] [Last]